1 Market Overview
    1.1 Gastrointestinal Stromal Tumor Drug Definition
    1.2 Global Gastrointestinal Stromal Tumor Drug Market Size and Forecast
        1.2.1 By Consumption Value, Global Gastrointestinal Stromal Tumor Drug Market Size, 2019-2030
        1.2.2 By Sales Quantity, Global Gastrointestinal Stromal Tumor Drug Market Size, 2019-2030
        1.2.3 Global Gastrointestinal Stromal Tumor Drug Average Selling Price (ASP), 2019-2030
    1.3 China Gastrointestinal Stromal Tumor Drug Market Size and Forecast
        1.3.1 By Consumption Value, China Gastrointestinal Stromal Tumor Drug Market Size, 2019-2030
        1.3.2 By Sales Quantity, China Gastrointestinal Stromal Tumor Drug Market Size, 2019-2030
        1.3.3 China Gastrointestinal Stromal Tumor Drug Average Selling Price (ASP), 2019-2030
    1.4 Share of China Gastrointestinal Stromal Tumor Drug Market with Respect to the Global Market
        1.4.1 By Consumption Value, China Gastrointestinal Stromal Tumor Drug Market Share in Global, 2019-2030
        1.4.2 By Sales Quantity, China Gastrointestinal Stromal Tumor Drug Market Share in Global, 2019-2030
        1.4.3 Gastrointestinal Stromal Tumor Drug Market Size: China VS Global, 2019-2030
    1.5 Gastrointestinal Stromal Tumor Drug Market Dynamics
        1.5.1 Gastrointestinal Stromal Tumor Drug Market Drivers
        1.5.2 Gastrointestinal Stromal Tumor Drug Market Restraints
        1.5.3 Gastrointestinal Stromal Tumor Drug Industry Trends
        1.5.4 Gastrointestinal Stromal Tumor Drug Industry Policy
2 Global Leading Manufacturers and Market Share
    2.1 By Revenue of Gastrointestinal Stromal Tumor Drug, Global Market Share by Company, 2019-2024
    2.2 By Sales Quantity of Gastrointestinal Stromal Tumor Drug, Global Market Share by Company, 2019-2024
    2.3 Gastrointestinal Stromal Tumor Drug Average Selling Price (ASP) by Company, 2019-2024
    2.4 Global Gastrointestinal Stromal Tumor Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    2.5 Global Gastrointestinal Stromal Tumor Drug Concentration Ratio
    2.6 Global Gastrointestinal Stromal Tumor Drug Mergers & Acquisitions, Expansion Plans
    2.7 Global Gastrointestinal Stromal Tumor Drug Manufacturers Product Type
    2.8 Head Office and Gastrointestinal Stromal Tumor Drug Production Site of Key Manufacturer
    2.9 Gastrointestinal Stromal Tumor Drug Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
    3.1 By Revenue of Gastrointestinal Stromal Tumor Drug, China Market Share by Company, 2019-2024
    3.2 By Sales Quantity of Gastrointestinal Stromal Tumor Drug, China Market Share by Company, 2019-2024
    3.3 China Gastrointestinal Stromal Tumor Drug Gastrointestinal Stromal Tumor Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
    4.1 Global Gastrointestinal Stromal Tumor Drug Capacity, Output and Capacity Utilization, 2019-2030
    4.2 Global Gastrointestinal Stromal Tumor Drug Capacity by Region
    4.3 Global Gastrointestinal Stromal Tumor Drug Production & Forecast by Region, 2019 VS 2023 VS 2030
    4.4 Global Gastrointestinal Stromal Tumor Drug Production by Region, 2019-2030
    4.5 Global Gastrointestinal Stromal Tumor Drug Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
    5.1 Gastrointestinal Stromal Tumor Drug Industry Chain
    5.2 Gastrointestinal Stromal Tumor Drug Upstream Analysis
        5.2.1 Gastrointestinal Stromal Tumor Drug Core Raw Materials
        5.2.2 Main Manufacturers of Gastrointestinal Stromal Tumor Drug Core Raw Materials
    5.3 Midstream Analysis
    5.4 Downstream Analysis
    5.5 Gastrointestinal Stromal Tumor Drug Production Mode
    5.6 Gastrointestinal Stromal Tumor Drug Procurement Model
    5.7 Gastrointestinal Stromal Tumor Drug Industry Sales Model and Sales Channels
        5.7.1 Gastrointestinal Stromal Tumor Drug Sales Model
        5.7.2 Gastrointestinal Stromal Tumor Drug Typical Distributors
6 Sights by Product Type
    6.1 Gastrointestinal Stromal Tumor Drug Classification
        6.1.1 Imatinib
        6.1.2 Sunitinib
        6.1.3 Regorafenib
        6.1.4 Ripretinib
        6.1.5 Others
    6.2 by Type, Global Gastrointestinal Stromal Tumor Drug Consumption Value & CAGR, 2019 VS 2023 VS 2030
    6.3 by Type, Global Gastrointestinal Stromal Tumor Drug Consumption Value, 2019-2030
    6.4 by Type, Global Gastrointestinal Stromal Tumor Drug Sales Quantity, 2019-2030
    6.5 by Type, Global Gastrointestinal Stromal Tumor Drug Average Selling Price (ASP), 2019-2030
7 Sights by Application
    7.1 Gastrointestinal Stromal Tumor Drug Segment by Application
        7.1.1 Hospital
        7.1.2 Clinic
        7.1.3 Others
    7.2 by Application, Global Gastrointestinal Stromal Tumor Drug Consumption Value & CAGR, 2019 VS 2023 VS 2030
    7.3 by Application, Global Gastrointestinal Stromal Tumor Drug Consumption Value, 2019-2030
    7.4 by Application, Global Gastrointestinal Stromal Tumor Drug Sales Quantity, 2019-2030
    7.5 by Application, Global Gastrointestinal Stromal Tumor Drug Price, 2019-2030
8 Sales Sights by Region
    8.1 By Region, Global Gastrointestinal Stromal Tumor Drug Consumption Value, 2019 VS 2023 VS 2030
    8.2 By Region, Global Gastrointestinal Stromal Tumor Drug Consumption Value, 2019-2030
    8.3 By Region, Global Gastrointestinal Stromal Tumor Drug Sales Quantity, 2019-2030
    8.4 North America
        8.4.1 North America Gastrointestinal Stromal Tumor Drug Market Size & Forecasts, 2019-2030
        8.4.2 By Country, North America Gastrointestinal Stromal Tumor Drug Market Size Market Share
    8.5 Europe
        8.5.1 Europe Gastrointestinal Stromal Tumor Drug Market Size & Forecasts, 2019-2030
        8.5.2 By Country, Europe Gastrointestinal Stromal Tumor Drug Market Size Market Share
    8.6 Asia Pacific
        8.6.1 Asia Pacific Gastrointestinal Stromal Tumor Drug Market Size & Forecasts, 2019-2030
        8.6.2 By Country/Region, Asia Pacific Gastrointestinal Stromal Tumor Drug Market Size Market Share
    8.7 South America
        8.7.1 South America Gastrointestinal Stromal Tumor Drug Market Size & Forecasts, 2019-2030
        8.7.2 By Country, South America Gastrointestinal Stromal Tumor Drug Market Size Market Share
    8.8 Middle East & Africa
9 Sales Sights by Country Level
    9.1 By Country, Global Gastrointestinal Stromal Tumor Drug Market Size & CAGR, 2019 VS 2023 VS 2030
    9.2 By Country, Global Gastrointestinal Stromal Tumor Drug Consumption Value, 2019-2030
    9.3 By Country, Global Gastrointestinal Stromal Tumor Drug Sales Quantity, 2019-2030
    9.4 U.S.
        9.4.1 U.S.Gastrointestinal Stromal Tumor Drug Market Size, 2019-2030
        9.4.2 by Type, U.S. Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share, 2023 VS 2030
        9.4.3 by Application, U.S. Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share, 2023 VS 2030
    9.5 Europe
        9.5.1 Europe Gastrointestinal Stromal Tumor Drug Market Size, 2019-2030
        9.5.2 by Type, Europe Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share, 2023 VS 2030
        9.5.3 by Application, Europe Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share, 2023 VS 2030
    9.6 China
        9.6.1 China Gastrointestinal Stromal Tumor Drug Market Size, 2019-2030
        9.6.2 by Type, China Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share, 2023 VS 2030
        9.6.3 by Application, China Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share, 2023 VS 2030
    9.7 Japan
        9.7.1 Japan Gastrointestinal Stromal Tumor Drug Market Size, 2019-2030
        9.7.2 by Type, Japan Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share, 2023 VS 2030
        9.7.3 by Application, Japan Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share, 2023 VS 2030
    9.8 South Korea
        9.8.1 South Korea Gastrointestinal Stromal Tumor Drug Market Size, 2019-2030
        9.8.2 by Type, South Korea Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share, 2023 VS 2030
        9.8.3 by Application, South Korea Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share, 2023 VS 2030
    9.9 Southeast Asia
        9.9.1 Southeast Asia Gastrointestinal Stromal Tumor Drug Market Size, 2019-2030
        9.9.2 by Type, Southeast Asia Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share, 2023 VS 2030
        9.9.3 by Application, Southeast Asia Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share, 2023 VS 2030
    9.10 India
        9.10.1 India Gastrointestinal Stromal Tumor Drug Market Size, 2019-2030
        9.10.2 by Type, India Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share, 2023 VS 2030
        9.10.3 by Application, India Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share, 2023 VS 2030
    9.11 Middle East & Africa
        9.11.1 Middle East & Africa Gastrointestinal Stromal Tumor Drug Market Size, 2019-2030
        9.11.2 by Type, Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share, 2023 VS 2030
        9.11.3 by Application, Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share, 2023 VS 2030
10 Manufacturers Profile
    10.1 Novartis
        10.1.1 Novartis Company Information, Head Office, Market Area, and Industry Position
        10.1.2 Novartis Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
        10.1.3 Novartis Gastrointestinal Stromal Tumor Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
        10.1.4 Novartis Company Profile and Main Business
        10.1.5 Novartis Recent Developments
    10.2 Bayer Pharmaceuticals
        10.2.1 Bayer Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
        10.2.2 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
        10.2.3 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
        10.2.4 Bayer Pharmaceuticals Company Profile and Main Business
        10.2.5 Bayer Pharmaceuticals Recent Developments
    10.3 Glenmark Pharmaceuticals Ltd.
        10.3.1 Glenmark Pharmaceuticals Ltd. Company Information, Head Office, Market Area, and Industry Position
        10.3.2 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
        10.3.3 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
        10.3.4 Glenmark Pharmaceuticals Ltd. Company Profile and Main Business
        10.3.5 Glenmark Pharmaceuticals Ltd. Recent Developments
    10.4 Sun Pharmaceuticals
        10.4.1 Sun Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
        10.4.2 Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
        10.4.3 Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
        10.4.4 Sun Pharmaceuticals Company Profile and Main Business
        10.4.5 Sun Pharmaceuticals Recent Developments
    10.5 Actavis Generics
        10.5.1 Actavis Generics Company Information, Head Office, Market Area, and Industry Position
        10.5.2 Actavis Generics Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
        10.5.3 Actavis Generics Gastrointestinal Stromal Tumor Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
        10.5.4 Actavis Generics Company Profile and Main Business
        10.5.5 Actavis Generics Recent Developments
    10.6 Dr. Reddy's Laboratories
        10.6.1 Dr. Reddy's Laboratories Company Information, Head Office, Market Area, and Industry Position
        10.6.2 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
        10.6.3 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
        10.6.4 Dr. Reddy's Laboratories Company Profile and Main Business
        10.6.5 Dr. Reddy's Laboratories Recent Developments
    10.7 Teva Pharmaceutical Industries Ltd.
        10.7.1 Teva Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area, and Industry Position
        10.7.2 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
        10.7.3 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
        10.7.4 Teva Pharmaceutical Industries Ltd. Company Profile and Main Business
        10.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments
    10.8 Apotex Inc.
        10.8.1 Apotex Inc. Company Information, Head Office, Market Area, and Industry Position
        10.8.2 Apotex Inc. Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
        10.8.3 Apotex Inc. Gastrointestinal Stromal Tumor Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
        10.8.4 Apotex Inc. Company Profile and Main Business
        10.8.5 Apotex Inc. Recent Developments
    10.9 Mylan Pharms Inc.
        10.9.1 Mylan Pharms Inc. Company Information, Head Office, Market Area, and Industry Position
        10.9.2 Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
        10.9.3 Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
        10.9.4 Mylan Pharms Inc. Company Profile and Main Business
        10.9.5 Mylan Pharms Inc. Recent Developments
    10.10 Bulat Pharmaceutical
        10.10.1 Bulat Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
        10.10.2 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
        10.10.3 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
        10.10.4 Bulat Pharmaceutical Company Profile and Main Business
        10.10.5 Bulat Pharmaceutical Recent Developments
    10.11 MSN Laboratories
        10.11.1 MSN Laboratories Company Information, Head Office, Market Area, and Industry Position
        10.11.2 MSN Laboratories Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
        10.11.3 MSN Laboratories Gastrointestinal Stromal Tumor Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
        10.11.4 MSN Laboratories Company Profile and Main Business
        10.11.5 MSN Laboratories Recent Developments
    10.12 Vannsh Life Sciences
        10.12.1 Vannsh Life Sciences Company Information, Head Office, Market Area, and Industry Position
        10.12.2 Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
        10.12.3 Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
        10.12.4 Vannsh Life Sciences Company Profile and Main Business
        10.12.5 Vannsh Life Sciences Recent Developments
    10.13 Beacon Pharmaceuticals
        10.13.1 Beacon Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
        10.13.2 Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
        10.13.3 Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
        10.13.4 Beacon Pharmaceuticals Company Profile and Main Business
        10.13.5 Beacon Pharmaceuticals Recent Developments
    10.14 Drug International
        10.14.1 Drug International Company Information, Head Office, Market Area, and Industry Position
        10.14.2 Drug International Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
        10.14.3 Drug International Gastrointestinal Stromal Tumor Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
        10.14.4 Drug International Company Profile and Main Business
        10.14.5 Drug International Recent Developments
    10.15 Deciphera Pharmaceuticals
        10.15.1 Deciphera Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
        10.15.2 Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
        10.15.3 Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
        10.15.4 Deciphera Pharmaceuticals Company Profile and Main Business
        10.15.5 Deciphera Pharmaceuticals Recent Developments
    10.16 CSPC Pharmaceuticals
        10.16.1 CSPC Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
        10.16.2 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
        10.16.3 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
        10.16.4 CSPC Pharmaceuticals Company Profile and Main Business
        10.16.5 CSPC Pharmaceuticals Recent Developments
    10.17 Hansoh Pharmaceuticals
        10.17.1 Hansoh Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
        10.17.2 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
        10.17.3 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
        10.17.4 Hansoh Pharmaceuticals Company Profile and Main Business
        10.17.5 Hansoh Pharmaceuticals Recent Developments
    10.18 Kelun Pharmaceuticals
        10.18.1 Kelun Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
        10.18.2 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
        10.18.3 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
        10.18.4 Kelun Pharmaceuticals Company Profile and Main Business
        10.18.5 Kelun Pharmaceuticals Recent Developments
    10.19 Zai Lab
        10.19.1 Zai Lab Company Information, Head Office, Market Area, and Industry Position
        10.19.2 Zai Lab Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
        10.19.3 Zai Lab Gastrointestinal Stromal Tumor Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
        10.19.4 Zai Lab Company Profile and Main Business
        10.19.5 Zai Lab Recent Developments
    10.20 CStone Pharmaceuticals
        10.20.1 CStone Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
        10.20.2 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
        10.20.3 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
        10.20.4 CStone Pharmaceuticals Company Profile and Main Business
        10.20.5 CStone Pharmaceuticals Recent Developments
    10.21 China Biopharmaceuticals
        10.21.1 China Biopharmaceuticals Company Information, Head Office, Market Area, and Industry Position
        10.21.2 China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Models, Specifications, and Application
        10.21.3 China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
        10.21.4 China Biopharmaceuticals Company Profile and Main Business
        10.21.5 China Biopharmaceuticals Recent Developments
11 Conclusion
12 Appendix
    12.1 Research Methodology
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Market Estimation Model
    12.4 Disclaimer